NASDAQ:LEXX

Lexaria Gets Attention with GLP-1 Test on Deck
····

Lexaria Gets Attention with GLP-1 Test on Deck

Lexaria Bioscience shares closed at $0.65 on Friday, up 7.33%, and resume Nasdaq trading Tuesday after the holiday. The company plans to start dosing in a human study comparing its DehydraTECH-semaglutide pills to Novo Nordisk’s Wegovy in mid-June. Lexaria extended a pharma partnership deal through the end of 2026. Its latest filing cited “substantial doubt” about ongoing operations without new funding.
May 26, 2026

Stock Market Today

  • Endeavour Group (ASX:EDV) Shares Drop 26% in 3 Months, Valuation at 20% Undervalued
    May 29, 2026, 11:50 PM EDT. Endeavour Group (ASX:EDV) shares have slid about 15% in the past month and 26% over three months, closing at A$2.88. This drop contrasts with analyst estimates placing fair value at A$3.61, signaling a potential 20.2% undervaluation. The company's growth outlook rests heavily on expanding online and omnichannel sales, driven by younger consumers favoring digital retail channels. Sustained revenue growth and improved margins underpin the bullish valuation, but risks remain from cost pressures, competitive pricing, and regulatory changes affecting its high-margin hotel operations. Investors face divergent sentiment, balancing near-term risks against a longer-term recovery in earnings multiples.